Phreesia (PHR)
(Delayed Data from NYSE)
$20.61 USD
+1.79 (9.51%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $20.61 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
C Value A Growth A Momentum A VGM
Brokerage Reports
Phreesia, Inc. [PHR]
Reports for Purchase
Showing records 1 - 20 ( 170 total )
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Profits Cash Generation Clearly in Focus; See Pathway to Consistent 15%+ Growth at MSD Margins
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Phreesia, Inc.
Industry: Medical Info Systems
Top- and Bottom-Line Beat; Pushes Out Initial FY25 Revenue Guidance to FY26
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Proprietary Healthcare - Credit Card Transaction Data
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Company: Phreesia, Inc.
Industry: Medical Info Systems
Continue to Like the 2H + FY25 Setup on Multi-Pronged Platform with Growth from Higher-Margin Contributions; Remain OW
Provider: KeyBanc Capital Markets
Analyst: Research Department